The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing novel immuno-oncology therapeutics.

Total Raised

$127 M

Rounds

7

Links

Verticals

Biotechnology
Health Care
Medical Device
Pharmaceutical

Investment History

  1. Series B

    Jun 2024

    $86M

  2. Equity

    Dec 2022

    $16M

  3. Debt Financing

    Sep 2022

    $0M

  4. Series A

    Jul 2020

    $6M

  5. Series A

    Jan 2020

    $17M

Team

Catherine Pickering

CEO

Joanna C. Horobin

Non Executive Chair of the Board of Directors

Karolina Niewola-Staszkowska

Sales and Support

Paramjit Kaur

Healthcare